Recombinant Human Anti-IgG Fc Antibody scFv Fragment
CAT#: MHH-548-S(P)
Recombinant Human Antibody scFv Fragment specifically reacts with IgG Fc, expressed in E. coli.
Specifications
- Immunogen
- Immunoglobulin G Fc
- Host Species
- Human
- Derivation
- Human
- Type
- scFv
- Specificity
- Tested positive against native Immunoglobulin G Fc
- Applications
- Products can be used for: Western blot; Enzyme-linked Immunosorbent Assay; Immunohistochemistry; Functional Study
Product Property
- Purity
- >97%, by SDS-PAGE under reducing conditions
- Storage
- Store at -20°C. Avoid multiple freeze/thaw cycles.
Target
- Alternative Names
- IgG Fc; Immunoglobulin G Fc
REVIEWS AND Q&AS
CITATIONS
RESOURCES
DOWNLOADS
RELATED PRODUCTS
Inquiry
Navs
Customer Review
There are currently no Customer reviews or questions for MHH-548-S(P). Click the button above to contact us or submit your feedback about this product.
High purity and affinity
The high purity and affinity of this scFv fragment streamlined our protein interaction studies, providing clear and interpretable data.
Low cross-reactivity
This reagent's low cross-reactivity with IgG from other species was crucial for our cross-species comparison studies. It has outperformed other reagents we've used.
Great for WB
We achieved excellent Western blot results using this scFv fragment. However, we had to optimize the blocking conditions a bit more than usual to get the best results.
Q&As
-
Can this single-chain variable fragment (scFv) be utilized in enzyme-linked immunosorbent assay (ELISA) procedures?
A: Yes, the Recombinant Human Anti-IgG Fc Antibody scFv Fragment is suitable for use in ELISA to detect human IgG.
-
Is this scFv fragment compatible with Western blotting?
A: Yes, it can be utilized in Western blotting applications to detect the Fc region of human IgG proteins.
-
Can the scFv fragment be conjugated to labels such as enzymes or fluorophores?
A: Yes, this scFv fragment can be conjugated to various labels including enzymes, fluorophores, and biotin for diverse applications.
View the frequently asked questions answered by Creative Biolabs Support.
Cite This Product
To accurately reference this product in your publication, please use the following citation information:
(Creative Biolabs Cat# MHH-548-S(P), RRID: AB_3111460)
Copy citation
Submit Your Publication
Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.
Downloadable Resources
Download resources about recombinant antibody development and antibody engineering to boost your research.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Datasheet
MSDS
COA
Certificate of Analysis LookupTo download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number:
Protocol & Troubleshooting
We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.
See other products for "IgG Fc"
Select a product category from the dropdown menu below to view related products.
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-548 | Recombinant Anti-IgG Fc Antibody | ELISA, WB, Dot, FuncS | IgG |
| MHH-548 | Recombinant Human Anti-IgG Fc Antibody | IF, Neut, FuncS | IgG |
| FAMAB-0023JF | Human Anti-IgG Fc Recombinant Antibody (clone A4) | ELISA, FuncS | Human IgM |
| FAMAB-0024JF | Human Anti-IgG Fc Recombinant Antibody (clone NA6) | ELISA, FuncS | Human IgM |
| VS3-FY2935 | Mouse Anti-IgG Fc Recombinant Antibody (VS3-FY2935) | WB | Mouse IgG |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-548-F(E) | Recombinant Anti-IgG Fc Antibody Fab Fragment | ELISA, IP, FuncS | Fab |
| MHH-548-F(E) | Recombinant Human Anti-IgG Fc Antibody Fab Fragment | WB, Dot, FuncS | Fab |
| PFBZ-080 | Human Anti-IgG Fc Recombinant Antibody; Fab Fragment (PFBZ-080) | WB, IF, FuncS | Human Fab |
| FAMAB-0023JF-F(E) | Human Anti-IgG Fc Recombinant Antibody (clone A4); Fab Fragment | WB, FC, ELISA, FuncS | Human Fab |
| FAMAB-0024JF-F(E) | Human Anti-IgG Fc Recombinant Antibody (clone NA6); Fab Fragment | WB, FC, ELISA, FuncS | Human Fab |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-548-S(P) | Recombinant Anti-IgG Fc Antibody scFv Fragment | WB, IF, FuncS | scFv |
| PSBZ-080 | Human Anti-IgG Fc Recombinant Antibody; scFv Fragment (PSBZ-080) | WB, IF, FuncS | Human scFv |
| HPAB-S0071-YC-S(P) | Human Anti-IgG Fc Recombinant Antibody (clone RF-AN); scFv Fragment | ELISA | Human scFv |
| FAMAB-0023JF-S(P) | Human Anti-IgG Fc Recombinant Antibody (clone A4); scFv Fragment | WB, FC, ELISA, FuncS | Human scFv |
| FAMAB-0024JF-S(P) | Human Anti-IgG Fc Recombinant Antibody (clone NA6); scFv Fragment | WB, FC, ELISA, FuncS | Human scFv |
| CAT | Product Name | Application | Type |
|---|---|---|---|
| MOB-0356MC | FITC anti-Human IgG Fc Antibody | FC |
Specific Inquiry
Add to compare
See Our Custom Production in Action
Popular Products
Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
Application: IP, IF, FuncS, FC, Neut, ELISA, ICC
Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
Application: Neut, ELISA, IF, IP, FuncS, FC, WB
Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
Application: WB, ELISA, IF, FuncS, Apop, BA
Application: ELISA, Vaccine, FuncS
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
